contacts Sign In
image
author Image

Becton Dickinson shares hit record high after US FDA clears return of drug infusion system

  • Home
  • Healthcare
  • Becton Dickinson shares hit record high after US FDA clears return of drug infusion system
Becton Dickinson said it expects to begin shipping the devices and recognizing revenue in its fiscal year 2024. It said it does not expect any material incremental revenue contribution from the Alaris infusion system for the rest of fiscal year 2023, which ends Sept. 30.